Molina Healthcare’s (MOH) Equal Weight Rating Reiterated at Stephens

Stephens reaffirmed their equal weight rating on shares of Molina Healthcare (NYSE:MOH) in a report issued on Thursday, Benzinga reports. They currently have a $320.00 target price on the stock.

Other equities analysts have also issued research reports about the company. Jefferies Financial Group decreased their target price on Molina Healthcare from $354.00 to $297.00 and set a hold rating for the company in a research report on Wednesday. JPMorgan Chase & Co. cut their target price on shares of Molina Healthcare from $420.00 to $395.00 and set an overweight rating for the company in a research report on Wednesday, July 10th. Robert W. Baird assumed coverage on Molina Healthcare in a report on Thursday, May 30th. They issued an outperform rating and a $405.00 price objective for the company. Wells Fargo & Company dropped their target price on Molina Healthcare from $375.00 to $315.00 and set an equal weight rating on the stock in a research report on Monday. Finally, Barclays reduced their price target on shares of Molina Healthcare from $437.00 to $430.00 and set an equal weight rating for the company in a research report on Thursday, April 25th. One analyst has rated the stock with a sell rating, five have issued a hold rating, six have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, Molina Healthcare currently has a consensus rating of Moderate Buy and a consensus target price of $376.18.

Molina Healthcare Stock Up 12.3 %

Shares of Molina Healthcare stock opened at $324.25 on Thursday. The company has a 50-day simple moving average of $307.61 and a two-hundred day simple moving average of $353.85. Molina Healthcare has a 52-week low of $282.96 and a 52-week high of $423.92. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.49 and a current ratio of 1.49. The stock has a market capitalization of $19.00 billion, a PE ratio of 17.59, a price-to-earnings-growth ratio of 0.89 and a beta of 0.58.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Wednesday, July 24th. The company reported $5.86 earnings per share for the quarter, topping analysts’ consensus estimates of $5.73 by $0.13. Molina Healthcare had a net margin of 2.84% and a return on equity of 29.17%. The company had revenue of $9.88 billion during the quarter, compared to analyst estimates of $9.75 billion. During the same period in the previous year, the business earned $5.65 EPS. The firm’s revenue for the quarter was up 18.7% on a year-over-year basis. On average, analysts anticipate that Molina Healthcare will post 23.56 EPS for the current fiscal year.

Insider Buying and Selling at Molina Healthcare

In other news, Director Ronna Romney sold 250 shares of the firm’s stock in a transaction on Tuesday, May 21st. The shares were sold at an average price of $343.27, for a total transaction of $85,817.50. Following the sale, the director now directly owns 16,945 shares in the company, valued at approximately $5,816,710.15. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Molina Healthcare news, COO James Woys sold 10,000 shares of the stock in a transaction that occurred on Wednesday, May 22nd. The shares were sold at an average price of $345.15, for a total transaction of $3,451,500.00. Following the completion of the sale, the chief operating officer now directly owns 53,613 shares of the company’s stock, valued at approximately $18,504,526.95. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Ronna Romney sold 250 shares of the business’s stock in a transaction on Tuesday, May 21st. The stock was sold at an average price of $343.27, for a total transaction of $85,817.50. Following the completion of the transaction, the director now directly owns 16,945 shares in the company, valued at approximately $5,816,710.15. The disclosure for this sale can be found here. Insiders own 1.10% of the company’s stock.

Institutional Trading of Molina Healthcare

A number of institutional investors and hedge funds have recently bought and sold shares of MOH. Quent Capital LLC boosted its holdings in shares of Molina Healthcare by 6.8% during the 1st quarter. Quent Capital LLC now owns 489 shares of the company’s stock valued at $201,000 after purchasing an additional 31 shares during the last quarter. Desjardins Global Asset Management Inc. boosted its stake in Molina Healthcare by 4.4% during the fourth quarter. Desjardins Global Asset Management Inc. now owns 763 shares of the company’s stock valued at $276,000 after buying an additional 32 shares during the last quarter. Clear Creek Financial Management LLC grew its holdings in Molina Healthcare by 2.2% during the 1st quarter. Clear Creek Financial Management LLC now owns 1,462 shares of the company’s stock valued at $601,000 after buying an additional 32 shares in the last quarter. Ritholtz Wealth Management increased its stake in Molina Healthcare by 2.1% in the 4th quarter. Ritholtz Wealth Management now owns 1,620 shares of the company’s stock worth $585,000 after acquiring an additional 33 shares during the last quarter. Finally, GAMMA Investing LLC raised its holdings in shares of Molina Healthcare by 11.5% during the 1st quarter. GAMMA Investing LLC now owns 330 shares of the company’s stock worth $136,000 after acquiring an additional 34 shares in the last quarter. 98.50% of the stock is currently owned by institutional investors.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.